已收盤 08-03 16:00:00 美东时间
0.000
0.00%
Oncology Institute (NASDAQ:TOI) raises FY2026 sales outlook from $630.000 million-$650.000 million to $650.000 million-$670.000 million vs $651.941 million estimate.
08-07 05:32
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $161.2...
08-07 05:28
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36
今日重点评级关注:Roth Capital:维持Nuvectis Pharma"买入"评级,目标价从20美元升至33美元;摩根士丹利:维持GXO Logistics"超配"评级,目标价从75美元升至78美元
07-07 11:34
Lake Street analyst Ben Haynor initiates coverage on Oncology Institute (NASDAQ:TOI) with a Buy rating and announces Price Target of $10.
07-06 23:53
今日重点评级关注:Chardan Capital:维持SAB Biotherapeutics"买入"评级,目标价从14美元升至16美元;Northland Capital Markets:维持Applied Digital"跑赢大市"评级,目标价从56美元升至82美元
06-18 19:08
Needham analyst Matthew Shea maintains Oncology Institute (NASDAQ:TOI) with a Buy and raises the price target from $5 to $7.
06-17 18:17
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5.25美元升至5.5美元;Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从9美元升至9.25美元
06-09 11:33
Shares of healthcare providers and services companies are trading higher amid s...
06-05 01:23